The current studies showed that autophagy blockage using combination therapy is an emerging model in cancer treatment and could sensitize cancer cells to investigational therapeutics; hence, autophagy blockage may enhance the pro-apoptotic effects of PI3K/mTOR inhibitors in preclinical studies [16,24] and it is evident that our results support the latter. This evidence concerns the gene PIK3CA and cancer.